Haen Sebastian P, Pereira Philippe L, Salih Helmut R, Rammensee Hans-Georg, Gouttefangeas Cécile
Abteilung II fuer Onkologie, Haematologie, Immunologie, Rheumatologie, und Pulmologie, Medizinische Universitaetsklinik, Otfried Mueller Straße 10, 72076 Tuebingen, Germany.
Clin Dev Immunol. 2011;2011:160250. doi: 10.1155/2011/160250. Epub 2011 Dec 29.
Over the past decades, thermoablative techniques for the therapy of localized tumors have gained importance in the treatment of patients not eligible for surgical resection. Anecdotal reports have described spontaneous distant tumor regression after thermal ablation, indicating a possible involvement of the immune system, hence an induction of antitumor immunity after thermoinduced therapy. In recent years, a growing body of evidence for modulation of both adaptive and innate immunity, as well as for the induction of danger signals through thermoablation, has emerged. Induced immune responses, however, are mostly weak and not sufficient for the complete eradication of established tumors or durable prevention of disease progression, and combination therapies with immunomodulating drugs are being evaluated with promising results. This article aims to summarize published findings on immune modulation through radiofrequency ablation, cryoablation, microwave ablation therapy, high-intensity focused ultrasound, and laser-induced thermotherapy.
在过去几十年中,热消融技术在治疗无法进行手术切除的局部肿瘤患者方面变得越来越重要。轶事报道描述了热消融后远处肿瘤的自发消退,这表明免疫系统可能参与其中,因此热诱导治疗后可诱导抗肿瘤免疫。近年来,越来越多的证据表明热消融可调节适应性免疫和先天性免疫,并诱导危险信号。然而,诱导的免疫反应大多较弱,不足以完全根除已形成的肿瘤或持久预防疾病进展,目前正在评估免疫调节药物联合治疗,结果令人鼓舞。本文旨在总结关于通过射频消融、冷冻消融、微波消融治疗、高强度聚焦超声和激光诱导热疗进行免疫调节的已发表研究结果。